These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 3856977)

  • 1. [Tumor-associated markers as organ-specific antigens of human seminal plasma. I. Immunologic studies].
    Höller U; Uhlenbruck G; Dienst C; Dreessen C
    Z Hautkr; 1985 Jan; 60(1-2):147-56. PubMed ID: 3856977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Tumor associated markers as organ-specific antigens of the human seminal plasma. II. Immunohistological studies].
    Dienst C; Uhlenbruck G; Heising J; Höller U; Dreessen C
    Z Hautkr; 1985 Jan; 60(1-2):157-64. PubMed ID: 2580399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sialylated Lea blood group substances detected by the monoclonal antibody Ca 19-9 in human seminal plasma and other organs.
    Uhlenbruck G; Höller U; Heising J; van Mil A; Dienst C
    Urol Res; 1985; 13(5):223-6. PubMed ID: 3864309
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Biological significance of tumor marker].
    Ochi Y
    Rinsho Byori; 1985 Aug; 33(8):831-8. PubMed ID: 3908745
    [No Abstract]   [Full Text] [Related]  

  • 5. [Serum carbohydrate 19-9 Tm and bronchial cancer. Comparative study with another tumor marker, carcinoembryonic antigen].
    Bisset JP; Kleisbauer JP; Roux F; Treffot MJ
    Pathol Biol (Paris); 1985 Jun; 33(6):672-6. PubMed ID: 3900886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Diagnostic value of a new serum marker of human digestive cancer: the carbohydrate antigen 19.9; comparison with the carcinoembryonic antigen].
    Olsson NO; Crimet-Montange D; Martin F
    Gastroenterol Clin Biol; 1985 Mar; 9(3):206-11. PubMed ID: 3859449
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carcinoembryonic antigen and blood group-related carbohydrate antigens in glycoproteins in human bile in hepatolithiasis. Japanese Study Group of Hepatolithiasis.
    Sasaki M; Morita T; Hoso M; Nakanuma Y; Tanimura H
    Hepatology; 1996 Feb; 23(2):258-63. PubMed ID: 8591850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CEA and CA 19.9: an evaluation by new statistical technics on a group of elderly patients].
    Gardini SL; Sergiacomi U; Colarossi GG
    Quad Sclavo Diagn; 1987 Mar; 23(1):32-42. PubMed ID: 3481647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Course of the serum determination of 4 tumor markers in viral hepatitis].
    Coda C; Lanza E; Ciambellotti E; Cartia GL; Moro G
    Minerva Med; 1987 Nov; 78(21):1577-81. PubMed ID: 3479707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Neoplasm markers useful for diagnosis and monitoring of colonic neoplasms].
    Ławicki S; Mroczko B; Szmitkowski M
    Postepy Hig Med Dosw; 2002; 56(5):617-34. PubMed ID: 12596691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunocytochemical evaluation of human prostatic carcinomas for carcinoembryonic antigen, nonspecific cross-reacting antigen, beta-chorionic gonadotrophin, and prostate-specific antigen.
    Purnell DM; Heatfield BM; Trump BF
    Cancer Res; 1984 Jan; 44(1):285-92. PubMed ID: 6197163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carcinoembryonic antigen activity in human seminal plasma.
    Asseo PP; Panidis DK; Papaloucas AC
    Int J Fertil; 1986; 30(4):53-6. PubMed ID: 2890596
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Quality control of the RIA method for 3 tumor markers].
    Fusco A; Ciarniello P; Latella G; Milani C; Antonucci M; Scuderi A; Giannoni MF; Caprilli R
    Minerva Med; 1987 Apr; 78(7):463-4. PubMed ID: 3472102
    [No Abstract]   [Full Text] [Related]  

  • 14. [CEA, CA 19.9 and CA 195 in patients with colorectal carcinoma. ROC analysis].
    Vallejo J; Torres-Avisbal M; Contreras P; Rodríguez-Liñán M; Rebollo A; González F; Benítez A; Infante J; Mateo A
    Rev Esp Med Nucl; 1999 Aug; 18(4):281-6. PubMed ID: 10481111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical experience with the tumor marker Ca 19-9 in an unselected group of more than 300 tumor patients.
    Souchon R; Koppenhagen K; Souchon MF; Matthes M; Boese-Landgraf J; Fitzner R; Baer U
    Cancer Detect Prev; 1985; 8(1-2):101-9. PubMed ID: 3864534
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Radioimmunoassays in oncology].
    Dressler J
    Fortschr Med; 1983 Mar; 101(11):451-4. PubMed ID: 6189774
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical evaluation of M43: a novel cancer-associated mucin epitope.
    Goodgame R; Kiefe C; Rose E; Sutton F; Brown J; Alpert E
    Cancer Res; 1993 Jun; 53(12):2803-9. PubMed ID: 7684947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitation of seminal factor IX and factor IXa in fertile, nonfertile, and vasectomy subjects: a step closer toward identifying a functional clotting system in human semen.
    Lwaleed BA; Greenfield RS; Hicks J; Birch BR; Cooper AJ
    J Androl; 2005; 26(1):146-52. PubMed ID: 15611579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical evaluation of CA 19-9 for the detection of malignant tumors--a comparison with CEA and IAP].
    Furukawa M; Kazaka S; Kushibiki K; Ashida Y; Saito H; Yamamoto H; Furukawa T
    Gan No Rinsho; 1984 Apr; 30(4):357-62. PubMed ID: 6587133
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Immunohistochemical evaluation of several tumor markers (CEA, ferritin, Ca) and their correlation with estro-progestin receptor state in neoplasms].
    Forti E; Wolf D; Melia M
    Pathologica; 1985; 77(1049):241-9. PubMed ID: 3913892
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.